Aurobindo Pharma Ltd

AUROPHARMA

Company Profile

  • Business description

    Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.

  • Contact

    Plot No. 1, Survey No. 83/1
    Galaxy, Floors 22-24
    Hyderabad Knowledge City
    Raidurg Panmaktha, Ranga Reddy District
    HyderabadTG500032
    IND

    T: +91 4066725000

    https://www.aurobindo.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    40,750

Stocks News & Analysis

stocks

Fears of deteriorating loan quality sends bank share plummeting

We maintain our fair value estimate despite unfavourable economic conditions.
stocks

Why it’s not all bad news for Flight Centre following downgrade

Despite an earnings downgrade, shares in FLT remain undervalued.
stocks

Chart of the Week: What 650 IPOs reveal about long-term performance

Our data shows buying into the IPO hype can be costly.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,964.201.20-0.01%
CAC 408,384.8746.74-0.55%
DAX 4024,671.22323.61-1.29%
Dow JONES (US)51,876.1144.51-0.09%
FTSE 10010,508.0221.87-0.21%
HKSE22,671.86405.05-1.76%
NASDAQ25,297.6260.99-0.24%
Nikkei 22569,360.883,005.46-4.15%
NZX 50 Index13,495.242.190.02%
S&P 5007,354.023.47-0.05%
S&P/ASX 2008,764.200.200.00%
SSE Composite Index4,027.2693.02-2.26%

Market Movers